Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
August 22, 2016 – The FDA approved a new update to the Warnings and Precautions section of the Movantik (naloxegol) drug label, regarding severe abdominal pain and/or diarrhea.
Return to publications